secwatch / observer
8-K filed November 30, 2021, 6:59 PM ET ticker HCIL CIK 0001086303
leadership confidence high sentiment neutral materiality 0.35

Heyu Biological appoints Bo Lyu as CFO effective Nov. 30, 2021

Hongchang International Co., Ltd

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Bo Lyu

Chief Financial Officer
HCIL · Hongchang International Co., Ltd
Effective
2021-11-30
Filed
November 30, 2021, 6:59 PM ET
On November 30,2021, Mr. Bo Lyu was appointed by the board of directors of Heyu Biological Technology Corporation (the “Company”) as the Company’s Chief Financial Officer, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Bo Lyu was appointed as Chief Financial Officer at Hongchang International Co., Ltd.

Action
appointed
Role
Chief Financial Officer
Exact text from the filing
On November 30,2021, Mr. Bo Lyu was appointed by the board of directors of Heyu Biological Technology Corporation (the “Company”) as the Company’s Chief Financial Officer, effective immediately.
View on SEC.gov

Hongchang International Co., Ltd filing history →

Source: SEC EDGAR
accession 0001213900-21-062445
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.